SB 1242
Modifies provisions relating to certain COVID-19 medications
LR Number:
Last Action:
3/29/2022 - Second Read and Referred S Professional Registration Committee
Journal Page:
Calendar Position:
Effective Date:
August 28, 2022

Current Bill Summary

SB 1242 - Under this act, the Board of Registration for the Healing Arts and the Board of Pharmacy shall not deny, revoke, suspend, or otherwise take any disciplinary action against a physician or pharmacist who prescribes, dispenses, distributes, or sells ivermectin or hydroxychloroquine sulfate tablets for human use for COVID-19.

Additionally, any physician or pharmacist who prescribes, dispenses, administers, sells, or otherwise distributes such medication shall be immune from civil liability for acts or omissions, unless the damages were caused by gross negligence or by willful or wanton acts or omissions; provided, that the physician or pharmacist exercised independent medical judgment and acted with the belief that the prescription, dispensation, administration, sale, or distribution of such medication was in the best interest of the patient and the patient provides written, informed consent, as defined in the act.

This act is substantially similar to provisions in the truly agreed to and finally passed CCS#2/SS/HB 2149 (2022) and SCS/SB 1133 (2022).



No Amendments Found.